To the contrary, our results showed that TPC was even significantly higher in VEGF-C 152s-treated mice compared to PBS-treated mice (Fig. 6e), suggesting that the beneficial effect of VEGF-C 152s on lymphatic function in the early stage of atherosclerosis is not related to decreased hypercholesterolemia. The gene discussed is VEGFC; the disease is Hypercholesterolemia.